Novitas BKK Tender

Contract notice: Completion of a non-excl. discount agreement according to § 130a para. 8 sgb v on valproic acid atc code: n03ag01 for the period from 05/01/2022 to 04/30/2024 The present announcement serves to conclude drug discount agreements in accordance with § 130a para. 8 sgb v about the active substance(s) mentioned under point ii.1.1). it is not a question of awarding public contracts within the meaning of directive 2014/24/eu or Sections 97 et seq. Gwb. any pharmaceutical company can be a contractual partner according to § 4 para. will be 18 mg. according to ecj jurisprudence, such approval procedures are not necessarily subject to public procurement law, since there is no competition due to the lack of a selection decision. the announcement serves as an invitation to conclude discount contracts with conditions that apply equally to all contractual partners and are non-dispositive, including the determination of the discount. the contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the contact point named under i.3).The earliest start of the contract is May 1st, 2022, provided that the signed contract and the required declarations have been received by the contact point named under i.3) by April 5th, 2022. the information in iv.2.2) refers to this. If the contract is received later, the start of the contract is the 1st of the month following the month in which the signed contract and the required declarations or evidence were received by the contact point specified under i.3), provided that the receipt is by the 5th of the month ; otherwise the 1st of the month after next. the contracts end automatically without the need for termination as soon as contracts are concluded for the active substance(s) or the active substance combination(s) as part of a procurement procedure. the contracts end on 04/30/2024